Fate Therapeutics
FATE
#8778
Rank
โ‚น14.68 B
Marketcap
โ‚น127.32
Share price
2.19%
Change (1 day)
-14.29%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: โ‚น14.68 Billion

As of February 2026 Fate Therapeutics has a market cap of โ‚น14.68 Billion. This makes Fate Therapeutics the world's 8778th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น14.68 B41.83%
2025โ‚น10.35 B-34.17%
2024โ‚น15.73 B-48.76%
2023โ‚น30.69 B-62.16%
2022โ‚น81.13 B-80.49%
2021โ‚น415.86 B-28.32%
2020โ‚น580.17 B448.97%
2019โ‚น105.68 B82.1%
2018โ‚น58.03 B182.61%
2017โ‚น20.53 B190.92%
2016โ‚น7.05 B9.76%
2015โ‚น6.43 B-1.92%
2014โ‚น6.55 B-17.29%
2013โ‚น7.92 B

End of Day market cap according to different sources

On Feb 19th, 2026 the market cap of Fate Therapeutics was reported to be:

โ‚น14.68 Billion
by Nasdaq info icon info icon
โ‚น14.68 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Becton Dickinson
BDX
โ‚น6.011 T 40,835.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น177.15 B 1,106.24%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น510.38 B 3,375.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น1.187 T 7,985.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚น1.023 T 6,869.54%๐Ÿ‡บ๐Ÿ‡ธ USA